Home/Filings/4/0001140361-21-033143
4//SEC Filing

Sherpa Ventures Fund, LP 4

Accession 0001140361-21-033143

CIK 0001628945other

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 5:35 PM ET

Size

25.4 KB

Accession

0001140361-21-033143

Insider Transaction Report

Form 4
Period: 2021-09-28
Transactions
  • Conversion

    Common Stock

    2021-09-28+4,926,4175,120,448 total(indirect: See footnote.)
  • Conversion

    Series B Preferred Stock

    2021-09-283,076,2240 total(indirect: See footnote.)
    Common Stock (3,076,224 underlying)
  • Conversion

    Series B Preferred Stock

    2021-09-283,834,0880 total(indirect: See footnote.)
    Common Stock (3,834,088 underlying)
  • Conversion

    Series C-1 Preferred Stock

    2021-09-281,092,3290 total(indirect: See footnote.)
    Common Stock (1,092,329 underlying)
  • Conversion

    Series A Preferred Stock

    2021-09-285,450,8980 total(indirect: See footnote.)
    Common Stock (5,450,898 underlying)
  • Conversion

    Series C-1 Preferred Stock

    2021-09-281,092,3290 total(indirect: See footnote.)
    Common Stock (1,092,329 underlying)
  • Conversion

    Common Stock

    2021-09-28+9,619,4519,748,805 total(indirect: See footnote.)
  • Other

    Common Stock

    2021-09-28$12.80/sh+371,293$4,752,5505,491,741 total(indirect: See footnote.)
Transactions
  • Conversion

    Common Stock

    2021-09-28+9,619,4519,748,805 total(indirect: See footnote.)
  • Conversion

    Series A Preferred Stock

    2021-09-285,450,8980 total(indirect: See footnote.)
    Common Stock (5,450,898 underlying)
  • Conversion

    Series C-1 Preferred Stock

    2021-09-281,092,3290 total(indirect: See footnote.)
    Common Stock (1,092,329 underlying)
  • Conversion

    Common Stock

    2021-09-28+4,926,4175,120,448 total(indirect: See footnote.)
  • Other

    Common Stock

    2021-09-28$12.80/sh+371,293$4,752,5505,491,741 total(indirect: See footnote.)
  • Conversion

    Series B Preferred Stock

    2021-09-283,076,2240 total(indirect: See footnote.)
    Common Stock (3,076,224 underlying)
  • Conversion

    Series B Preferred Stock

    2021-09-283,834,0880 total(indirect: See footnote.)
    Common Stock (3,834,088 underlying)
  • Conversion

    Series C-1 Preferred Stock

    2021-09-281,092,3290 total(indirect: See footnote.)
    Common Stock (1,092,329 underlying)
Transactions
  • Conversion

    Series A Preferred Stock

    2021-09-285,450,8980 total(indirect: See footnote.)
    Common Stock (5,450,898 underlying)
  • Other

    Common Stock

    2021-09-28$12.80/sh+371,293$4,752,5505,491,741 total(indirect: See footnote.)
  • Conversion

    Common Stock

    2021-09-28+9,619,4519,748,805 total(indirect: See footnote.)
  • Conversion

    Series B Preferred Stock

    2021-09-283,076,2240 total(indirect: See footnote.)
    Common Stock (3,076,224 underlying)
  • Conversion

    Common Stock

    2021-09-28+4,926,4175,120,448 total(indirect: See footnote.)
  • Conversion

    Series C-1 Preferred Stock

    2021-09-281,092,3290 total(indirect: See footnote.)
    Common Stock (1,092,329 underlying)
  • Conversion

    Series B Preferred Stock

    2021-09-283,834,0880 total(indirect: See footnote.)
    Common Stock (3,834,088 underlying)
  • Conversion

    Series C-1 Preferred Stock

    2021-09-281,092,3290 total(indirect: See footnote.)
    Common Stock (1,092,329 underlying)
Transactions
  • Other

    Common Stock

    2021-09-28$12.80/sh+371,293$4,752,5505,491,741 total(indirect: See footnote.)
  • Conversion

    Series A Preferred Stock

    2021-09-285,450,8980 total(indirect: See footnote.)
    Common Stock (5,450,898 underlying)
  • Conversion

    Series B Preferred Stock

    2021-09-283,834,0880 total(indirect: See footnote.)
    Common Stock (3,834,088 underlying)
  • Conversion

    Series B Preferred Stock

    2021-09-283,076,2240 total(indirect: See footnote.)
    Common Stock (3,076,224 underlying)
  • Conversion

    Series C-1 Preferred Stock

    2021-09-281,092,3290 total(indirect: See footnote.)
    Common Stock (1,092,329 underlying)
  • Conversion

    Common Stock

    2021-09-28+9,619,4519,748,805 total(indirect: See footnote.)
  • Conversion

    Common Stock

    2021-09-28+4,926,4175,120,448 total(indirect: See footnote.)
  • Conversion

    Series C-1 Preferred Stock

    2021-09-281,092,3290 total(indirect: See footnote.)
    Common Stock (1,092,329 underlying)
Footnotes (6)
  • [F1]On September 28, 2021, the Series A Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
  • [F2]On September 28, 2021, the Series B Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
  • [F3]On September 28, 2021, the Series C-1 Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
  • [F4]The shares are held directly by Sherpa Ventures Fund, LP ("ACME I"). Sherpa Ventures Fund GP, LLC ("ACME GP I") is the general partner of ACME I. Each of the reporting persons disclaims beneficial ownership of the shares reported herein except to the extent of its respective pecuniary interest therein.
  • [F5]The shares are held directly by Sherpa Ventures Fund II, LP ("ACME II"). Sherpa Ventures Fund II GP, LLC ("ACME GP II") is the general partner of ACME II. Each of the reporting persons disclaims beneficial ownership of the shares reported herein except to the extent of its respective pecuniary interest therein.
  • [F6]On September 28, 2021, outstanding principal and accrued interest underlying a convertible note automatically converted into Common Stock upon the closing of the initial public offering of the Issuer's common stock at a conversion price equal to 80% of the initial public offering price per share.

Issuer

Cue Health Inc.

CIK 0001628945

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001580437

Filing Metadata

Form type
4
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 5:35 PM ET
Size
25.4 KB